日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Educational programme for glaucoma patients: an effective public health intervention in Kazakhstan

针对青光眼患者的教育计划:哈萨克斯坦一项有效的公共卫生干预措施

Bhatnagar, Anshul; Scherer, Rafael; Samico, Gustavo A; Muralidhar, Rohit; Gutkind, Naomi E; Palazoni, Vitoria; Medeiros, Felipe A; Swaminathan, Swarup S; Taushanova, M; Yermukhanova, L

Patient Satisfaction with the Expanded Nurses Service in Primary Health Care: Evidence from Kazakhstan

哈萨克斯坦的证据表明,患者对基层医疗保健中扩大护士服务的满意度

Abdikadirova, Indira; Yermukhanova, Lyudmila; Blaževičiene, Aurelija; Dostanova, Zhanar; Baigozhina, Zaure; Taushanova, Maiya; Sultanova, Gulnar; Almagul, Kauysheva

Characteristics of the needs of older people in Kazakhstan: a cross-sectional muliticentre study

哈萨克斯坦老年人需求特征:一项横断面多中心研究

Yermukhanova, Lyudmila; Kimatova, Kerbez; Suwalska, Aleksandra; Philp, Ian; Dworacka, Marzena; Aitmaganbet, Perizat; Tazhbenova, Saule; Taushanova, Maiya; Kurmanalina, Gulnara; Talarska, Dorota; Wieczorowska-Tobis, Katarzyna; Tobis, Slawomir

Machine Learning Approach for Muscovy Duck (Cairina moschata) Semen Quality Assessment

基于机器学习的麝香鸭(Cairina moschata)精液质量评估方法

Abadjieva, Desislava; Georgiev, Boyko; Gerzilov, Vasko; Tsvetkova, Ilka; Taushanova, Paulina; Todorova, Krassimira; Hayrabedyan, Soren

Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting

保加利亚转移性乳腺癌一线内分泌治疗患者中PIK3CA突变的患病率和预后

Gencheva, R; Petrova, M; Kraleva, P; Hadjidekova, S; Radanova, M; Conev, N; Stoyanov, D; Arabadjiev, J; Tazimova, E; Bachurska, S; Eneva, M; Tsvetkova, M; Zhbantov, G; Karanikolova, T; Manov, D; Ivanova, A; Taushanova-Hadjieva, M; Staneva, R; Dimitrova, E; Donev, I

Synchronous Occurrence of Triple-Negative Breast Cancer and Malignant Melanoma

三阴性乳腺癌与恶性黑色素瘤的同步发生

Taushanova, Margarita Stoyanova; Milusheva, Yoana Ivanova; Manov, Dimo Angelov; Hadjieva, Ralitza Rosen; Yordanov, Angel Danchev

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer

肌少症和高中性粒细胞/淋巴细胞比值(NLR)与非小细胞肺癌患者二线帕博利珠单抗治疗后出现超进展性疾病相关。

Petrova, M P; Donev, I S; Radanova, M A; Eneva, M I; Dimitrova, E G; Valchev, G N; Minchev, V T; Taushanova, M S; Boneva, M V; Karanikolova, T S; Gencheva, R B; Zhbantov, G A; Ivanova, A I; Timcheva, C V; P Pavlov, B; Megdanova, V G; Robev, B S; Conev, N V